Quest Diagnostics Incorporated
Quest Diagnostics Incorporated
Quest Diagnostics Incorporated
DGX
DGX
NYSE
Health Services
Services to the Health Industry
227.86
USD
-0.04
-0.02%
Geschlossen: 07-24 20:00 (UTC+0)
227.86
USD
+0
+0.00%
Nachbörslich: 07-25 00:00 (UTC+0)

DGX Wichtige Statistiken

Hoch
233.21
Öffnen
228.00
Volumen
1.54M
Niedrig
223.42
Vorheriger Schlusskurs
227.90
Handelswert
353.86M
52W-Hoch
237.78
Rel. Volumen
1.414
Amplitude (%)
4.30%
52W-Tief
165.78
Umsatzrate
1.39%
Marktkapitalisierung
25.14B
KGV (TTM)
24.17
KGV (Jährlich)
25.689
KBV
3.35
KUV
2.18
Gewinn je Aktie (EPS)
9.427
Dividende (TTM)
3.737
Dividendenrendite
1.44%
Ausstehende Aktien
110.69M
Währung
USD

DGX Preis-Performance

7 Tag
30 Tag
90 Tag
180 Tag
Seit Jahresbeginn
1 Jahr
DGX Moneyflow-Verteilung
DGX Tägliches Leerverkaufsvolumen
DGX Short-Interest-Historie
As of 2026-07-26, the Quest Diagnostics Incorporated (DGX) stock price today is 227.86. Based on this price, the company has a market capitalization of $25.14B, with a P/E ratio of 24.17. On 2026-07-26, DGX traded between 223.42 and 233.21. Today’s stock price is 1.99% above the daily low and 2.29% below the daily high, placing DGX in der Mitte von its most recent trading range. Trading volume currently stands at 1.54M, compared with an average daily volume of 1.09M. This suggests that trading activity is über dem üblichen Niveau than usual. Over the past year, Quest Diagnostics Incorporated shares have traded between 165.78 and 237.78. At today’s price, DGX is 37.45% above its 52-week low and 4.17% below its 52-week high.
Firmenname
Quest Diagnostics Incorporated
Sektor
Health Services
Branche
Services to the Health Industry
Börsen
NYSE
Anzahl der Beschäftigten
57,000
Losgröße
100
Offizielle Website
Währung
USD
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

DGX FAQ